ArticleBMJ open2021

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).

Paul Noel Brennan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.